September 19, 2021

Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Post-Exposure Prophylaxis for COVID-19

SHANGHAI, China, Sept. 19, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the United States Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) for etesevimab (JS016/LY-CoV016) 1,400 mg and bamlanivimab (LY-CoV555) […]

Read More

‘Compassion Fatigue’ Hitting US Doctors, Report Says

A report in The Guardian says U.S. physicians treating unvaccinated patients are “succumbing to compassion fatigue” as a fourth surge of COVID-19 cases sweeps across the country.Dr. Michelle Shu, a 29-year-old emergency medicine resident, said medical …

Read More

Recent Posts